Which is worse atrial fibrillation or ventricular tachycardia

Atrial Fibrillation and Ventricular Arrhythmias: Sex Differences in Electrophysiology, Epidemiology, Clinical Presentation, and Clinical Outcomes

Anne M Gillis. Circulation. 2017.

Abstract

Sex-specific differences in the epidemiology, pathophysiology, clinical presentation, clinical treatment, and clinical outcomes of atrial fibrillation (AF), sustained ventricular arrhythmias, and sudden cardiac death are recognized. Sex hormones cause differences in cardiac electrophysiological parameters between men and women that may affect the risk for arrhythmias. The incidence and prevalence of AF is lower in women than in men. However, because women live longer and AF prevalence increases with age, the absolute number of women with AF exceeds that of men. Women with AF are more symptomatic, present with more atypical symptoms, and report worse quality of life in comparison with men. Female sex is an independent risk factor for death or stroke attributable to AF. Oral anticoagulation therapy for stroke prevention has similar efficacy for men and women, but older women treated with warfarin have a higher residual risk of stroke in comparison with men. Women with AF are less likely to receive rhythm control antiarrhythmic drug therapy, electric cardioversion, or catheter ablation in comparison with men. The incidence and prevalence of sustained ventricular arrhythmias and sudden cardiac death are lower in women than in men. Women receiving implantable cardioverter defibrillators for primary prevention of sudden cardiac death are less likely to experience sustained ventricular arrhythmias in comparison with men. In contrast, women receiving a cardiac resynchronization therapy implantable cardioverter defibrillator for the treatment of heart failure are more likely to benefit than men. Women are less likely to be referred for implantable cardioverter defibrillator therapy despite current guideline recommendations. Women are more likely to experience a significant complication related to implantable cardioverter defibrillator implantation in comparison with men. Whether sex differences in treatment decisions reflect patient preferences or treatment biases requires further study.

Keywords: atrial fibrillation; death, sudden, cardiac; sex characteristics; stroke; tachycardia, ventricular; ventricular fibrillation.

© 2017 American Heart Association, Inc.

Similar articles

  • Outcome of invasive electrophysiological procedures and gender: are males and females the same?

    Santangeli P, di Biase L, Pelargonio G, Natale A. Santangeli P, et al. J Cardiovasc Electrophysiol. 2011 May;22(5):605-12. doi: 10.1111/j.1540-8167.2010.01920.x. Epub 2010 Oct 11. J Cardiovasc Electrophysiol. 2011. PMID: 20958833 Review.

  • Arrhythmias in women.

    Curtis AB, Narasimha D. Curtis AB, et al. Clin Cardiol. 2012 Mar;35(3):166-71. doi: 10.1002/clc.21975. Clin Cardiol. 2012. PMID: 22389121 Free PMC article. Review.

  • Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.

    Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Jones PW, Rousseau MJ, Hayes DL. Powell BD, et al. J Am Coll Cardiol. 2013 Oct 29;62(18):1674-1679. doi: 10.1016/j.jacc.2013.04.083. Epub 2013 Jun 27. J Am Coll Cardiol. 2013. PMID: 23810882

  • [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].

    Ohnishi S, Kasanuki H. Ohnishi S, et al. J Cardiol. 2000 Mar;35 Suppl 1:75-84. J Cardiol. 2000. PMID: 10834174 Review. Japanese.

Cited by

  • Visit-to-visit SBP variability and risk of atrial fibrillation in middle-aged and older populations.

    Wang C, Sun Y, Xin Q, Han X, Cai Z, Zhao M, Yun C, Zhang S, Hou Z, Chen S, Wu S, Xue H. Wang C, et al. J Hypertens. 2022 Dec 1;40(12):2521-2527. doi: 10.1097/HJH.0000000000003291. Epub 2022 Oct 10. J Hypertens. 2022. PMID: 36214547 Free PMC article.

  • Atrial Fibrillation as a Prognostic Indicator in Patients With Orthostatic Hypotension: Nationwide Inpatient Sample Analysis.

    Brgdar A, Gharbin J, Awan A, Ogunti R, Khurshid Q, Hamad M, Mehrotra P. Brgdar A, et al. Cardiol Res. 2022 Aug;13(4):228-235. doi: 10.14740/cr1405. Epub 2022 Aug 15. Cardiol Res. 2022. PMID: 36128415 Free PMC article.

  • Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation.

    Zhao M, Liu X, Bu X, Li Y, Wang M, Zhang B, Sun W, Li C. Zhao M, et al. PeerJ. 2022 Aug 9;10:e13853. doi: 10.7717/peerj.13853. eCollection 2022. PeerJ. 2022. PMID: 35966924 Free PMC article.

  • Sex Differences and Temporal Trends in Hospitalization for Catheter Ablation of Nonvalvular Atrial Fibrillation: A Single-Center Experience for 15 Years.

    Peng X, Li L, Zhang M, Zhao Q, Wu K, Bai R, Ruan Y, Ma C, Liu N. Peng X, et al. J Interv Cardiol. 2022 Jul 4;2022:6522261. doi: 10.1155/2022/6522261. eCollection 2022. J Interv Cardiol. 2022. PMID: 35873948 Free PMC article.

  • Association of Coffee Consumption With Atrial Fibrillation Risk: An Updated Dose-Response Meta-Analysis of Prospective Studies.

    Cao Y, Liu X, Xue Z, Yin K, Ma J, Zhu W, Liu F, Luo J, Sun J. Cao Y, et al. Front Cardiovasc Med. 2022 Jul 6;9:894664. doi: 10.3389/fcvm.2022.894664. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35872898 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

  • Full Text Sources

    • Atypon
    • Ingenta plc
    • Ovid Technologies, Inc.
  • Other Literature Sources

    • scite Smart Citations
  • Medical

    • MedlinePlus Health Information

How serious is ventricular tachycardia?

Ventricular tachycardia episodes may be brief and last only a couple of seconds without causing harm. But episodes lasting more than a few seconds (sustained V-tach ) can be life-threatening. Sometimes ventricular tachycardia can cause the heart to stop (sudden cardiac arrest).

What is the survival rate for ventricular tachycardia?

Among the high-risk group, 65.0% patients were survived and 52.1% patients were free from VT recurrence; within the medium- and low-risk groups, 84.0% and 97.2% patients survived, 72.4% and 88.4% were free from VT recurrence, respectively.

Is atrial fibrillation the same as tachycardia?

Atrial fibrillation (A-fib). This is the most common type of tachycardia. Chaotic, irregular electrical signals in the upper chambers of the heart (atria) cause a fast heartbeat. A-fib may be temporary, but some episodes won't end unless treated.

Which type of arrhythmia is the most serious?

The most serious arrhythmia is ventricular fibrillation, which is an uncontrolled, irregular beat. Instead of one misplaced beat from the ventricles, you may have several impulses that begin at the same time from different locations—all telling the heart to beat.